• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素与化疗药物联合应用增强癌症治疗效果的概述。

An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments.

机构信息

Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Via F. Delpino 1, 80137 Naples, Italy.

Research Institute on Terrestrial Ecosystems (IRET), UOS Naples-Consiglio Nazionale delle Ricerche (CNR), Via Pietro Castellino 111, 80131 Naples, Italy.

出版信息

Int J Mol Sci. 2023 Aug 9;24(16):12587. doi: 10.3390/ijms241612587.

DOI:10.3390/ijms241612587
PMID:37628772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10454892/
Abstract

Due to the progressive ageing of the human population, the number of cancer cases is increasing. For this reason, there is an urgent need for new treatments that can prolong the lives of cancer patients or ensure them a good quality of life. Although significant progress has been made in the treatment of cancer in recent years and the survival rate of patients is increasing, limitations in the use of conventional therapies include the frequent occurrence of side effects and the development of resistance to chemotherapeutic agents. These limitations are prompting researchers to investigate whether combining natural agents with conventional drugs could have a positive therapeutic effect in cancer treatment. Several natural bioactive compounds, especially polyphenols, have been shown to be effective against cancer progression and do not exert toxic effects on healthy tissues. Many studies have investigated the possibility of combining polyphenols with conventional drugs as a novel anticancer strategy. Indeed, this combination often has synergistic benefits that increase drug efficacy and reduce adverse side effects. In this review, we provide an overview of the studies describing the synergistic effects of curcumin, a polyphenol that has been shown to have extensive cytotoxic functions against cancer cells, including combined treatment. In particular, we have described the results of recent preclinical and clinical studies exploring the pleiotropic effects of curcumin in combination with standard drugs and the potential to consider it as a promising new tool for cancer therapy.

摘要

由于人类人口的老龄化进程不断推进,癌症病例的数量正在增加。出于这个原因,迫切需要新的治疗方法,这些方法可以延长癌症患者的生命或确保他们拥有良好的生活质量。尽管近年来在癌症治疗方面取得了重大进展,患者的生存率正在提高,但常规疗法的使用存在局限性,包括副作用频繁发生和对化疗药物产生耐药性。这些局限性促使研究人员研究是否可以将天然药物与常规药物结合使用,以对癌症治疗产生积极的治疗效果。一些天然生物活性化合物,特别是多酚,已被证明对癌症的进展具有有效作用,并且不会对健康组织产生毒性作用。许多研究已经探讨了将多酚与常规药物联合作为一种新的抗癌策略的可能性。事实上,这种联合治疗通常具有协同作用,可以提高药物疗效并减少不良反应。在这篇综述中,我们概述了描述姜黄素协同作用的研究,姜黄素是一种多酚,已被证明对癌细胞具有广泛的细胞毒性作用,包括联合治疗。特别是,我们描述了最近探索姜黄素与标准药物联合使用的多效性作用的临床前和临床研究结果,以及将其视为癌症治疗有前途的新工具的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010a/10454892/4eafe3c37181/ijms-24-12587-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010a/10454892/93e4ad7af66f/ijms-24-12587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010a/10454892/4eafe3c37181/ijms-24-12587-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010a/10454892/93e4ad7af66f/ijms-24-12587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010a/10454892/4eafe3c37181/ijms-24-12587-g002.jpg

相似文献

1
An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments.姜黄素与化疗药物联合应用增强癌症治疗效果的概述。
Int J Mol Sci. 2023 Aug 9;24(16):12587. doi: 10.3390/ijms241612587.
2
The Potential of Plant-Derived Extracts and Compounds to Augment Anticancer Effects of Chemotherapeutic Drugs.植物提取物和化合物增强化疗药物抗癌作用的潜力。
Nutr Cancer. 2022;74(9):3058-3076. doi: 10.1080/01635581.2022.2069274. Epub 2022 Jun 8.
3
Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.EGCG、鞣酸和姜黄素对癌细胞多药耐药的调节。
Phytomedicine. 2018 Nov 15;50:213-222. doi: 10.1016/j.phymed.2018.09.169. Epub 2018 Sep 17.
4
Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.表没食子儿没食子酸酯增强姜黄素诱导耐药乳腺癌细胞生长抑制和凋亡的作用。
Am J Chin Med. 2014;42(5):1279-300. doi: 10.1142/S0192415X14500803.
5
Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies-An Update Overview.在临床前和临床研究中使用选定多酚的联合化疗:更新概述。
Molecules. 2023 Apr 26;28(9):3746. doi: 10.3390/molecules28093746.
6
Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity.姜黄素和其他膳食多酚:代谢作用机制及治疗糖尿病和肥胖的潜力。
Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E201-E205. doi: 10.1152/ajpendo.00285.2017. Epub 2017 Oct 31.
7
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.多酚克服癌症药物耐药性的作用:全面综述。
Cell Mol Biol Lett. 2022 Jan 3;27(1):1. doi: 10.1186/s11658-021-00301-9.
8
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?姜黄素:改善结直肠癌患者生活质量的新途径?
Int J Mol Sci. 2022 Nov 14;23(22):14058. doi: 10.3390/ijms232214058.
9
Targeting microRNAs by curcumin: implication for cancer therapy.姜黄素靶向 microRNAs:癌症治疗的新策略。
Crit Rev Food Sci Nutr. 2022;62(28):7718-7729. doi: 10.1080/10408398.2021.1916876. Epub 2021 Apr 27.
10
An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy.探讨姜黄素(一种多酚类姜黄素)在糖尿病肾病中的保护作用及其分子机制。
Biomed Pharmacother. 2022 Sep;153:113438. doi: 10.1016/j.biopha.2022.113438. Epub 2022 Aug 1.

引用本文的文献

1
Unlocking the Potential of Nutraceuticals in Cancer Chemotherapy: A Comprehensive Review.释放营养保健品在癌症化疗中的潜力:一篇综述
Cureus. 2025 Aug 4;17(8):e89328. doi: 10.7759/cureus.89328. eCollection 2025 Aug.
2
Redefining Chemoresistance: Natural Bioactives as Molecular Modulators at the Cancer-Tumor Microenvironment Interface.重新定义化疗耐药性:天然生物活性物质作为癌症-肿瘤微环境界面的分子调节剂
Int J Mol Sci. 2025 Aug 20;26(16):8037. doi: 10.3390/ijms26168037.
3
Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α-p300/CBP alliance.

本文引用的文献

1
Curcumin combining temozolomide formed localized nanogel for inhibition of postsurgical chemoresistant glioblastoma.姜黄素联合替莫唑胺形成局部纳米凝胶抑制术后化疗抵抗性脑胶质母细胞瘤。
Nanomedicine (Lond). 2023 May;18(12):907-921. doi: 10.2217/nnm-2023-0058. Epub 2023 Jul 19.
2
Synergistic Effects of New Curcumin Analog (PAC) and Cisplatin on Oral Cancer Therapy.新型姜黄素类似物(PAC)与顺铂对口腔癌治疗的协同作用
Curr Issues Mol Biol. 2023 Jun 8;45(6):5018-5035. doi: 10.3390/cimb45060319.
3
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.
应对肿瘤缺氧:打破致癌性HIF-1α-p300/CBP联盟的进展
Invest New Drugs. 2025 Aug 21. doi: 10.1007/s10637-025-01570-3.
4
Phytochemical modulation of mTOR signaling: emerging nanotechnology-driven therapeutics for rheumatoid arthritis management.mTOR信号通路的植物化学调控:新兴的纳米技术驱动的类风湿关节炎治疗方法
Inflammopharmacology. 2025 Jul 22. doi: 10.1007/s10787-025-01844-5.
5
Pancreatic cancer: failures and hopes-a review of new promising treatment approaches.胰腺癌:失败与希望——新的有前景的治疗方法综述
Explor Target Antitumor Ther. 2025 Mar 18;6:1002299. doi: 10.37349/etat.2025.1002299. eCollection 2025.
6
Molecular Targets of Plant-Derived Bioactive Compounds in Oral Squamous Cell Carcinoma.植物源生物活性化合物在口腔鳞状细胞癌中的分子靶点
Cancers (Basel). 2024 Oct 26;16(21):3612. doi: 10.3390/cancers16213612.
7
Effect of Periodate-Induced Cross-linking on Dual Anticancer Drug Release from Poly(2-isopropyl-2-oxazoline)/Tannic Acid-Based Layer-by-Layer Microparticles.高碘酸盐诱导交联对聚(2-异丙基-2-恶唑啉)/单宁酸基层层组装微粒中双抗癌药物释放的影响
ACS Omega. 2024 Sep 11;9(38):39626-39642. doi: 10.1021/acsomega.4c03977. eCollection 2024 Sep 24.
8
Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review.姜黄素及其类似物靶向STAT3信号通路治疗乳腺癌:一项叙述性综述。
Animal Model Exp Med. 2024 Dec;7(6):853-867. doi: 10.1002/ame2.12491. Epub 2024 Sep 2.
9
Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.姜黄素:健康老龄化的黄金途径:证据的系统评价。
Nutrients. 2024 Aug 15;16(16):2721. doi: 10.3390/nu16162721.
10
Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights.用于克服姜黄素制剂挑战的纳米载体系统研究进展:当前见解
Nanomaterials (Basel). 2024 Apr 12;14(8):672. doi: 10.3390/nano14080672.
姜黄和姜黄素在慢性病防治中的作用:来自临床试验的经验教训。
ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14.
4
Curcumin Sensitizes 4T1 Murine Breast Cancer Cells to Cisplatin Through PAR4 Secretion.姜黄素通过 PAR4 分泌使 4T1 鼠乳腺癌细胞对顺铂敏感。
In Vivo. 2022 Nov-Dec;36(6):2767-2773. doi: 10.21873/invivo.13013.
5
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.帕博利珠单抗、放疗和免疫调节五药鸡尾酒治疗经治持续性、复发性或转移性宫颈癌或子宫内膜癌患者:PRIMMO 研究的 II 期结果。
Cancer Immunol Immunother. 2023 Feb;72(2):475-491. doi: 10.1007/s00262-022-03253-x. Epub 2022 Aug 12.
6
Curcumin Increased the Sensitivity of Non-Small-Cell Lung Cancer to Cisplatin through the Endoplasmic Reticulum Stress Pathway.姜黄素通过内质网应激途径增加非小细胞肺癌对顺铂的敏感性。
Evid Based Complement Alternat Med. 2022 Jun 17;2022:6886366. doi: 10.1155/2022/6886366. eCollection 2022.
7
Long-term Survival, Tolerability, and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer.在不可切除的转移性结直肠癌患者中,一线贝伐珠单抗和 FOLFIRI 联合载姜黄素的人参皂苷修饰纳米脂质载体的长期生存、耐受性和安全性。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221105498. doi: 10.1177/15347354221105498.
8
Curcumin inhibits the cancer‑associated fibroblast‑derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway.姜黄素通过抑制 JAK/STAT3 信号通路抑制胃癌相关成纤维细胞来源的化疗耐药性。
Int J Oncol. 2022 Jul;61(1). doi: 10.3892/ijo.2022.5375. Epub 2022 May 27.
9
Complex polymeric nanomicelles co-delivering doxorubicin and dimethoxycurcumin for cancer chemotherapy.载多柔比星和二甲氧基姜黄素的复杂聚合纳米胶束用于癌症化疗。
Drug Deliv. 2022 Dec;29(1):1523-1535. doi: 10.1080/10717544.2022.2073403.
10
A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors.一项关于姜黄素对实体瘤患者伊立替康剂量限制性毒性和药代动力学影响的 I 期评估。
Clin Transl Sci. 2022 May;15(5):1304-1315. doi: 10.1111/cts.13250. Epub 2022 Feb 26.